Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

被引：0
|
作者：
Samantha O‘Hagan Henderson
Jochen J. Frietsch
Inken Hilgendorf
Andreas Hochhaus
Claus-Henning Köhne
Jochen Casper
机构：
[1] Universitätsklinikum Oldenburg,Onkologie und Hämatologie
[2] Klinik Für Innere Medizin II,Abteilung Hämatologie und Internistische Onkologie
[3] Universitätsklinikum Jena,undefined
[4] Klinik Für Innere Medizin II,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
AML; MDS; MPN; Allogeneic stem cell transplantation; Toxicity-reduced conditioning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2599 / 2609
页数：10
相关论文
共 50 条
  • [1] Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms
    O'Hagan Henderson, Samantha
    Frietsch, Jochen J.
    Hilgendorf, Inken
    Hochhaus, Andreas
    Koehne, Claus-Henning
    Casper, Jochen
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2599 - 2609
  • [2] CONTINUOUS SEQUENTIAL INFUSION OF FLUDARABINE AND CYTARABINE FOR ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA SECONDARY TO MYELODYSPLASTIC SYNDROME
    Ferrara, F.
    Palmieri, S.
    Mele, G.
    Izzo, T.
    Criscuolo, C.
    Pedata, M.
    Riccardi, C.
    Pocali, B.
    Califano, C.
    D'Arco, A. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 118 - 118
  • [3] Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Deeg, H. Joachim
    Stevens, Emily A.
    Salit, Rachel B.
    Ermoian, Ralph P.
    Fang, Min
    Gyurkocza, Boglarka
    Sorror, Mohamed L.
    Fatobene, Giancarlo
    Baumgart, Joachim
    Burroughs, Lauri M.
    Delaney, Colleen
    Doney, Kris
    Egan, Daniel N.
    Flowers, Mary E. D.
    Milano, Filippo
    Radich, Jerry P.
    Scott, Bart L.
    Sickle, Eileen J.
    Wood, Brent L.
    Yeung, Cecilia
    Storer, Barry E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (05) : 956 - 963
  • [4] Treosulfan-fludarabine-cytarabine myeloablative conditioning for autologous stem cell transplantation in elderly patients with acute myeloid leukaemia and myelodysplastic syndrome in first complete remission
    Bernardi, M.
    Crotta, A.
    Messina, C.
    Peccatori, J.
    Tassara, M.
    Assanelli, A.
    Clerici, D.
    Giglio, F.
    Malato, S.
    Forno, B.
    Mastaglio, S.
    Girlanda, S.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S415 - S415
  • [5] Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome
    Yee, Karen W. L.
    Cortes, Jorge
    Ferrajoli, Alessandra
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    Wierda, William
    Thomas, Deborah
    Faderl, Stefan
    King, Ivan
    O'Brien, Susan M.
    Jeha, Sima
    Andreeff, Michael
    Cahill, Ann
    Sznol, Mario
    Giles, Francis J.
    LEUKEMIA RESEARCH, 2006, 30 (07) : 813 - 822
  • [6] Treosulfan, fludarabine and cytarabine (FLAT) myeloablative conditioning for autologous stem cell transplantation in elderly patients with acute myeloid leukemia in first complete remission
    Bernardi, Massimo
    Pavesi, Francesca
    Messina, Carlo
    Lorentino, Francesca
    Peccatori, Jacopo
    Assanelli, Andrea
    Vago, Luca
    Gentner, Bernhard
    Milani, Raffaella
    Casirati, Gabriele
    Sala, Elisa
    Mastaglio, Sara
    Ciceri, Fabio
    BONE MARROW TRANSPLANTATION, 2018, 53 : 192 - 192
  • [7] MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH FLUDARABINE
    Colovic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 506 - 506
  • [8] MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH FLUDARABINE
    Nomdedeu, J.
    Ferrari, A.
    Estivill, C.
    Hoyos, M.
    Esteve, J.
    Domingo, A.
    Tormo, M.
    Guardia, R.
    Bargay, J.
    Florensa, L.
    Queipo, M.
    Bussaglia, E.
    Carricondo, M.
    Gallardo, D.
    Ribera, J. M.
    Brunet, S.
    Aventin, A.
    Sierra, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 506 - 506
  • [9] Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
    Sud, Amit
    Chattopadhyay, Subhayan
    Thomsen, Hauke
    Sundquist, Kristina
    Sundquist, Jan
    Houlston, Richard S.
    Hemminki, Kari
    BLOOD, 2018, 132 (09) : 973 - 976
  • [10] Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG
    M G Martin
    G L Uy
    E Procknow
    K Stockerl-Goldstein
    A Cashen
    P Westervelt
    C N Abboud
    K Augustin
    J Luo
    J F DiPersio
    R Vij
    Bone Marrow Transplantation, 2009, 44 : 13 - 17
12345